Frost & Sullivan Research Service   Published: 18 Jan 2017
Disruptive Technologies and Game-changing Companies in the Global Pharmaceutical Cell Banking Market
  SERVICE HOMEPAGE
FURTHER INFORMATION
  Table Of Contents
  1 | DISRUPTIVE TECHNOLOGIES AND GAME-CHANGING COMPANIES IN THE GLOBAL PHARMACEUTICAL CELL BANKING MARKET
   Executive Summary
      1. Key Findings

  Market Overview
      1. Market Segment Overview
      2. Transformation in the Industry Ecosystem
      3. Industry Value Chain
      4. Game-changing Companies
      5. Cell Banking and Cell Line Development—Technology Trends
      6. 8 Big Market Themes for Cell Banking

  Technology Process Overview
      1. Technology Process Overview—Biopharmaceutical Production
      2. Technology Process Overview—Timelines of the End-to-End Services Provided by Multiple CMOs
      3. Technology Process Overview—Cell Banking
      4. Technology Process Overview—Cell Banking (continued)

  Key Technology Trends
      1. Key Technology Trends—Cell Banking

  Key Technologies
      1. Key Technologies—Perfusion Technology
      2. Key Technologies—Single-use Technology
      3. Single-use/Disposable Manufacturing Technology versus Traditional Large Capacity Stainless Steel Bioreactors
      4. Key Technologies—Cryopreservation Reagents and Upstream & Downstream Processes

  Key Technology Platforms
      1. High Growth in Mammalian Cell Culture Technology
      2. Mammalian Cell Culture Technology Platforms
      3. Mammalian Cell Culture Technology Platforms (continued)
      4. Microbial Cell Culture Technology

  Key Companies to Action
      1. Key Companies by Region
      2. Key Companies by Region (continued)
      3. SGS Life Sciences
      4. SGS Life Sciences (continued)
      5. SGS Life Sciences (continued)
      6. Charles River Laboratories
      7. Charles River Laboratories (continued)
      8. Charles River Laboratories (continued)
      9. Wuxi AppTech
      10. Wuxi AppTech (continued)
      11. Wuxi AppTech (continued)
      12. BioReliance Corporation
      13. BioReliance Corporation (continued)
      14. BioReliance Corporation (continued)
      15. Eurofins Scientific
      16. Eurofins Scientific (continued)
      17. Eurofins Scientific (continued)
      18. Lonza
      19. Lonza (continued)
      20. Lonza (continued)

  Key Mergers and Acquisitions and Partnerships and Collaborations
      1. Merger, Acquisition, and Partnership Assessment
      2. Merger, Acquisition, and Partnership Assessment (continued)

  Growth Opportunities
      1. 4 Major Growth Opportunities

   The Last Word
      1. The Last Word
      2. Legal Disclaimer

  The Frost & Sullivan Story
      1. The Frost & Sullivan Story
      2. Value Proposition: Future of Your Company & Career
      3. Global Perspective
      4. Industry Convergence
      5. 360º Research Perspective
      6. Implementation Excellence
      7. Our Blue Ocean Strategy

Conseq